Suppr超能文献

肝素结合蛋白抑制是否为白蛋白在人类感染性休克中疗效的机制?

Is Heparin-Binding Protein Inhibition a Mechanism of Albumin's Efficacy in Human Septic Shock?

机构信息

Department of Clinical Sciences, Division of Infection Medicine, Skåne University Hospital, Lund University, Lund, Sweden.

Department of Anesthesia and Intensive care, Helsingborg Hospital, Helsingborg, Sweden.

出版信息

Crit Care Med. 2018 May;46(5):e364-e374. doi: 10.1097/CCM.0000000000002996.

Abstract

OBJECTIVES

Our objectives were to determine first whether albumin prevents heparin-binding protein-induced increased endothelial cell permeability and renal cell inflammation and second, whether a plasma heparin-binding protein-to-albumin ratio predicts risk of acute kidney injury, fluid balance, and plasma cytokine levels in septic shock.

DESIGN

In vitro human endothelial and renal cell model and observation cohort of septic shock.

SETTINGS

Research laboratory and multicenter clinical trial (Vasopressin and Septic Shock Trial).

PATIENTS

Adult septic shock (norepinephrine dose > 5 μg/min for > 6 hr).

INTERVENTIONS

In vitro: heparin-binding protein (or thrombin) was added with or without albumin to 1) human endothelial cell monolayers to assess permeability and 2) to human renal tubular epithelial cells to assess inflammation.

MEASUREMENTS AND MAIN RESULTS

Transendothelial electrical resistance-a marker of permeability-of human endothelial cells was measured using a voltohmmeter. We measured plasma heparin-binding protein-to-albumin ratio and a panel of cytokines in septic shock patients (n = 330) to define an heparin-binding protein-to-albumin ratio that predicts risk of acute kidney injury. Albumin inhibited heparin-binding protein (and thrombin-induced) increased endothelial cell permeability at a threshold concentration of 20-30 g/L but increased renal tubular cell interleukin-6 release. Patients who developed or had worsened acute kidney injury had significantly higher heparin-binding protein-to-albumin ratio (1.6 vs 0.89; p < 0.001) and heparin-binding protein (38.2 vs 20.8 ng/mL; p < 0.001) than patients without acute kidney injury. The highest heparin-binding protein-to-albumin ratio (> 3.05), heparin-binding protein quartiles (> 69.8), and heparin-binding protein > 30 ng/mL were significantly associated with development or worsening of acute kidney injury (p < 0.001) in unadjusted and adjusted analyses and were robust to sensitivity analyses for death as a competing outcome. Heparin-binding protein and heparin-binding protein-to-albumin ratio were directly associated with positive fluid balance (p < 0.001) and with key inflammatory cytokines. Increasing quartiles of heparin-binding protein-to-albumin ratio and heparin-binding protein (but not albumin) were highly significantly associated with days alive and free of acute kidney injury and renal replacement therapy (p < 0.001), vasopressors (p < 0.001), ventilation (p < 0.001), and with 28-day mortality.

CONCLUSIONS

Albumin inhibits heparin-binding protein-induced increased human endothelial cell permeability and heparin-binding protein greater than 30 ng/mL and heparin-binding protein-to-albumin ratio greater than 3.01-but not serum albumin-identified patients at increased risk for acute kidney injury in septic shock.

摘要

目的

我们的目的首先是确定白蛋白是否可以预防肝素结合蛋白诱导的内皮细胞通透性增加和肾细胞炎症,其次是确定血浆肝素结合蛋白与白蛋白的比值是否可以预测脓毒症休克患者发生急性肾损伤、液体平衡和血浆细胞因子水平的风险。

设计

体外人内皮和肾细胞模型和脓毒症休克观察队列。

地点

研究实验室和多中心临床试验(加压素和脓毒性休克试验)。

患者

成人脓毒症休克(去甲肾上腺素剂量>5μg/min 超过 6 小时)。

干预措施

在体外:肝素结合蛋白(或凝血酶)与白蛋白一起加入 1)人内皮细胞单层以评估通透性,和 2)人肾小管上皮细胞以评估炎症。

测量和主要结果

使用电压计测量人内皮细胞的跨内皮电阻 - 通透性的标志物。我们测量了脓毒症休克患者的血浆肝素结合蛋白与白蛋白的比值和细胞因子谱(n=330),以确定预测急性肾损伤风险的肝素结合蛋白与白蛋白比值。白蛋白在 20-30g/L 的阈值浓度下抑制肝素结合蛋白(和凝血酶诱导的)增加的内皮细胞通透性,但增加了肾管状细胞白细胞介素-6 的释放。发生或急性肾损伤恶化的患者的肝素结合蛋白与白蛋白比值(1.6 比 0.89;p<0.001)和肝素结合蛋白(38.2 比 20.8ng/mL;p<0.001)明显高于没有急性肾损伤的患者。最高的肝素结合蛋白与白蛋白比值(>3.05)、肝素结合蛋白四分位数(>69.8)和肝素结合蛋白>30ng/mL 与急性肾损伤的发生或恶化(p<0.001)显著相关,在未调整和调整后的分析中均具有统计学意义,并且对死亡作为竞争结果的敏感性分析也是稳健的。肝素结合蛋白和肝素结合蛋白与白蛋白的比值与正性液体平衡直接相关(p<0.001),并与关键的炎症细胞因子相关。肝素结合蛋白与白蛋白比值和肝素结合蛋白四分位数的增加与存活且无急性肾损伤和肾脏替代治疗天数(p<0.001)、血管加压药(p<0.001)、通气(p<0.001)和 28 天死亡率显著相关(p<0.001)。

结论

白蛋白抑制肝素结合蛋白诱导的人内皮细胞通透性增加,肝素结合蛋白>30ng/mL 和肝素结合蛋白与白蛋白比值>3.01-但不是血清白蛋白-可识别出脓毒症休克患者发生急性肾损伤的风险增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验